Armata Pharmaceuticals (ARMP) EPS (Weighted Average and Diluted) (2016 - 2018)
Historic EPS (Weighted Average and Diluted) for Armata Pharmaceuticals (ARMP) over the last 6 years, with Q4 2018 value amounting to -$0.24.
- Armata Pharmaceuticals' EPS (Weighted Average and Diluted) rose 3228.38% to -$0.24 in Q4 2018 from the same period last year, while for Dec 2018 it was -$1.52, marking a year-over-year increase of 8211.76%. This contributed to the annual value of -$0.89 for FY2024, which is 5340.31% up from last year.
- Per Armata Pharmaceuticals' latest filing, its EPS (Weighted Average and Diluted) stood at -$0.24 for Q4 2018, which was up 3228.38% from -$0.6 recorded in Q3 2018.
- Over the past 5 years, Armata Pharmaceuticals' EPS (Weighted Average and Diluted) peaked at $1.18 during Q2 2015, and registered a low of -$9.66 during Q4 2016.
- In the last 5 years, Armata Pharmaceuticals' EPS (Weighted Average and Diluted) had a median value of -$0.66 in 2014 and averaged -$1.83.
- Per our database at Business Quant, Armata Pharmaceuticals' EPS (Weighted Average and Diluted) plummeted by 756216.45% in 2014 and then skyrocketed by 28808.68% in 2015.
- Quarter analysis of 5 years shows Armata Pharmaceuticals' EPS (Weighted Average and Diluted) stood at -$0.17 in 2014, then crashed by 248.03% to -$0.59 in 2015, then tumbled by 1543.1% to -$9.66 in 2016, then soared by 96.33% to -$0.35 in 2017, then soared by 32.28% to -$0.24 in 2018.
- Its EPS (Weighted Average and Diluted) stands at -$0.24 for Q4 2018, versus -$0.6 for Q3 2018 and -$0.68 for Q2 2018.